Digital survey on the intake and attitude of phytopharmaceuticals and medicinal cannabis in patients with inflammatory rheumatic and orthopedic diseases (digital cannabis in rheumatism and osteoarthritis study "iCanRAS")

Digital survey on the intake and attitude of phytopharmaceuticals and medicinal cannabis in patients with inflammatory rheumatic and orthopedic diseases (digital cannabis in rheumatism and osteoarthritis study "iCanRAS") - iCanRAS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030875

Enrollment

500

Registered

2022-12-16

Start date

2023-02-16

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with inflammatory rheumatic diseases and patients with orthopedic diseases

Interventions

Group 1: Patients with inflammatory rheumatic diseases Group 2: Patients with orthopedic diseases

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: sufficient German language skills

Exclusion criteria

Exclusion criteria: insufficient German language skills

Design outcomes

Primary

Measure	Time frame
The consumption of phytopharma as well as knowledge and attitudes towards medicinal cannabis in patients with inflammatory-rheumatic diseases and degenerative diseases will be concretized.	—

Secondary

Measure	Time frame
Possible similarities and differences will be presented.	—

Countries

Germany

Contacts

Public ContactJutta Richter

Universitätsklinikum Düsseldorf

jutta.richter@med.uni-duesseldorf.de+492118117817

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026